PROVIDER PROFILE · NPI 1053471045

Andre Lallande

Internal MedicineFontana, CAI

MEDICARE UTILIZATION · PART B · 2024

No data available for this provider in 2024.

PRESCRIBING · PART D · 2024

Total Rx claims

331

Beneficiaries

—

Total drug cost

$149K

Distinct drugs

Brand share

13.0%

Top prescribed drugs

Leflunomide51 claims

Hydroxychloroquine Sulfate48 claims

Prednisone48 claims

Celecoxib33 claims

Tofacitinib Citrate24 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Andre Lallande's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 3 inbound referrers · 4 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
Unilab Corporation Clinical Laboratory · West Hills, CA	16	140
RHEUMATOLOGY DIAGNOSTICS LABORATORY INC	11	129
SENAATI, SASSAN	11	133

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
SENAATI, SASSAN	34	742
Al Franco Rheumatology · Riverside, CA	33	611
Unilab Corporation Clinical Laboratory · West Hills, CA	32	430
John Crues Diagnostic Radiology · Los Angeles, CA	14	141

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history